## PNR: Pentair plc - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.1% below STRENGTH zone (4.0-10.0%); PEG 1.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($99.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. Pentair Director Glenn T Michael Sells Shares**
- Source: TradingView | 20251204T071658 | Somewhat-Bearish | Relevance: 100%
- Pentair Director Glenn T Michael sold 6,558 common shares on December 1, 2025, for a total of $684,196 at a price of $104.33 per share. Following this transaction, Michael directly owns 31,192 common shares and 1,659 common stock-restricted stock units of Pentair plc. This insider transaction is detailed in an SEC Filing Form 4.

**2. Schroder Investment Management Group Acquires 44,732 Shares of Pentair plc $PNR**
- Source: MarketBeat | 20251203T123710 | Bullish | Relevance: 100%
- Schroder Investment Management Group increased its stake in Pentair plc by 18.5%, acquiring an additional 44,732 shares, bringing their total holdings to 286,659 shares valued at $29.43 million. This comes as Pentair reported strong quarterly earnings, beating estimates with $1.24 EPS, and received a "Moderate Buy" consensus rating from analysts with an average target price of $119.85. Additionally, the article notes insider selling by CFO Robert P. Fishman and details other institutional investor activities, along with financial metrics and dividend information for Pentair.

**3. Dir Glenn Sells 6,558 ($684.2K) Of Pentair plc [PNR]**
- Source: TradingView | 20251203T071659 | Somewhat-Bearish | Relevance: 100%
- Glenn T Michael, a Director of Pentair plc (PNR), sold 6,558 shares of the company for $684,196 on December 1, 2025. This sale followed a planned exercise of 6,558 shares at a price of $32.83, totaling $215,299. The transaction was executed pursuant to a prearranged trading plan (10b5-1), leaving Michael with 32,852 direct holdings.

**4. Barclays downgrades Pentair (PNR)**
- Source: MSN | 20251205T040938 | Bearish | Relevance: 100%
- Barclays downgraded Pentair (PNR). Further details including the reason for the downgrade and any new price targets are not available from the provided input. This action by Barclays indicates a revised outlook on Pentair's financial performance or market position.

**5. Pentair (PNR) Sees Analyst Downgrade and Price Target Reduction by Barclays | PNR Stock News**
- Source: GuruFocus | 20251204T150047 | Bearish | Relevance: 100%
- Barclays has downgraded Pentair (PNR) to "Equal-Weight" from "Overweight" and reduced its price target to $115.00 from $127.00. This 9.45% decrease in the price target comes amidst other analysts maintaining or raising their targets for the water treatment industry leader. The average analyst target price for PNR is currently $122.25, indicating a potential upside of 14.82% from its current price, while GuruFocus' GF Value suggests a downside.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $115 | $127 | -9% |
| 2025-11-20 | Oppenheimer | $128 | $124 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | down | Equal-Weight |
| 2025-11-20 | Oppenheimer | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Blackrock Inc.: 9.4% (-10.2%)
- State Street Corpora: 5.3% (-2.7%)
- Price (T.Rowe) Assoc: 4.7% (+262.8%)
- FMR, LLC: 3.7% (+6.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.3B |
| Beta | 1.21 |
| 52W Range | $74.25 - $113.95 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 19.3 |
| Current P/E | 21.3 |
| YoY Growth | 10.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.5% to -3.1% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). RSI neutral at 44. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.15% (CS: 26) | Weak |
| RSI_14 | 43.9 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 0.991x | Below |
| vs SMA50 | 0.968x | Below |
| vs SMA200 | 1.038x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $104.25
- **Stop Loss:** $99.69 (4.4% risk)
- **Target:** $108.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 263
- **Position Value:** $27,417.75
- **Portfolio %:** 27.42%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.18 | $1.24 | +5.0% |
| 2025Q2 | $1.34 | $1.39 | +4.0% |
| 2025Q1 | $1.01 | $1.11 | +9.7% |
| 2024Q4 | $1.02 | $1.08 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*